Abstract
Studies of oral chemotherapy of 5-fluroruracil (5-FU) combined with FT-207, a furanyl analog of 5-FU, as an adjuvant to surgical treatment of stomach cancer have been performed since 1970 in the first department of surgery of Chiba University, Japan. These studies were performed on 107 patients with curative stomach cancer and 22 patients with non-curative stomach cancer. These patients received consecutively 3.5mg/kg/day of 5-FU and 8mg/kg/day of FT-207 for 24 to 36 months and were compared with control patients who had undergone only surgical treatment. A significant higher survival was observed in the curatively resected patients receiving oral 5-FU and FT-207, as compared to the control group. Studies on non-curative stomach cancer patients treated with the same dose schedule gave encouraging results. Because of the limited number of patients treated in this study, the drawing of reliable conclusions must wait the results of further studies.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dixon W. J., Longmire W. P., Jr, Holden W. D. Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma: ten-year follow-up. Ann Surg. 1971 Jan;173(1):26–39. doi: 10.1097/00000658-197101000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Douglass H. O., Jr, Mittelman A. Metabolic studies of 5-fluorouracil. II. Influence of the route of administration on the dynamics of distribution in man. Cancer. 1974 Dec;34(6):1878–1881. doi: 10.1002/1097-0142(197412)34:6<1878::aid-cncr2820340604>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- Fujimoto S., Akao T., Itol B., Koshizuka I., Koyano K. A study of survival in patients with stomach cancer treated by a combination of preoperative intra-arterial infusion therapy and surgery. Cancer. 1976 Apr;37(4):1648–1653. doi: 10.1002/1097-0142(197604)37:4<1648::aid-cncr2820370405>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Higgins G. A., Dwight R. W., Smith J. V., Keehn R. J. Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch Surg. 1971 Apr;102(4):339–343. doi: 10.1001/archsurg.1971.01350040101020. [DOI] [PubMed] [Google Scholar]
- Holden W. D., Dixon W. J., Kuzma J. W. The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal carcinoma. Ann Surg. 1967 Apr;165(4):481–503. doi: 10.1097/00000658-196704000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karrar K. Importance of dose schedules in adjuvant chemotherapy. Cancer Chemother Rep. 1972 Feb;56(1):35–45. [PubMed] [Google Scholar]
- Lawrence W., Jr, Terz J. J., Horsley S., 3rd, Donaldson M., Lovett W. L., Brown P. W., Ruffner B. W., Regelson W. Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg. 1975 May;181(5):616–623. doi: 10.1097/00000658-197505000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Long R. T., Donegan W. L., Evans A. M. Extended surgical adjuvant chemotherapy for breast carcinoma. Am J Surg. 1969 May;117(5):701–704. doi: 10.1016/0002-9610(69)90409-7. [DOI] [PubMed] [Google Scholar]
- Longmire W. P., Jr, Kuzma J. W., Dixon W. J. The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma. Ann Surg. 1968 Mar;167(3):293–312. doi: 10.1097/00000658-196803000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MRAZEK R., ECONOMOU S., MCDONALD G. O., SLAUGHTER D. P., COLE W. H. Prophylactic and adjuvant use of nitrogen mustard in the surgical treatment of cancer. Ann Surg. 1959 Oct;150:745–755. doi: 10.1097/00000658-195910000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanuki S., Fujimoto S., Watanabe Y. [Screening test of antineoplastic drugs by using tissue culture]. Saishin Igaku. 1969 Aug;24(8):1787–1790. [PubMed] [Google Scholar]